The Department of Defense offers the NFRP Investigator-Initiated Research Award to fund impactful NF research projects excluding clinical trials. Projects should adhere to rigorous study design standards for preclinical research. Applicants must provide relevant preliminary or published data and follow guidelines for animal research planning and reporting. Research ideas may stem from various sources and should aim to contribute significantly to NF research or patient care. The deadline for applications is July 27, 2015, 12:00 AM EDT.
Opportunity ID: 276385
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-15-NFRP-IIRA |
Funding Opportunity Title: | DoD Neurofibromatosis Investigator-Initiated Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 7 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 06, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jul 27, 2015 |
Current Closing Date for Applications: | Jul 27, 2015 |
Archive Date: | Aug 26, 2015 |
Estimated Total Program Funding: | $6,004,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that is relevant to NF and the proposed research project. Preclinical Research: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of preclinical research. The standards are described in Landis, S.C., et al. A call for transparent reporting to optimize the predictive value of preclinical research, Nature 2012, 490:187-191 (www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in research and should be applied. Projects that include research on animal models are required to submit Attachment 8, Animal Research Plan, as part of the application package to describe how these standards will be addressed. Applicants should consult the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines to ensure relevant aspects of rigorous animal research are adequately planned for and, ultimately, reported. The ARRIVE guidelines can be found at http://www.nc3rs.org.uk/page.asp?id=1357. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 276385 Full Announcement-1 -> nfrp_fy15_iira_pa_gg.pdf
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00216635 | May 06, 2015 | Jul 27, 2015 | View |
Package 1
Mandatory forms
276385 RR_SF424_2_0-2.0.pdf
276385 RR_Budget_1_3-1.3.pdf
276385 RR_KeyPersonExpanded_2_0-2.0.pdf
276385 PerformanceSite_2_0-2.0.pdf
Optional forms
276385 RR_SubawardBudget30_1_3-1.3.pdf